Cargando…
Revising our attitudes towards agonist medications and their diversion in a time of pandemic()
The COVID-19 pandemic led government regulators to relax prescribing rules for buprenorphine and methadone, the agonist medications that effectively treat opioid use disorder, allowing for take home supplies of up to 28 days. These changes prioritized the availability of these medications over conce...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505066/ https://www.ncbi.nlm.nih.gov/pubmed/33138924 http://dx.doi.org/10.1016/j.jsat.2020.108139 |